| Intrahepatic Cholangiocarcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 45show all (up to 200) |
|---|
| → investigated in trials for | Gemcitabinesmall molecule 24 trials (10 active) · roll-up of the cancer and its descendants | — | — | Intrahepatic Cholangiocarcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 20 trials (8 active) · roll-up of the cancer and its descendants | — | — | Intrahepatic Cholangiocarcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 16 trials (11 active) · roll-up of the cancer and its descendants | — | — | Intrahepatic Cholangiocarcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 13 trials (9 active) · roll-up of the cancer and its descendants | — | — | Intrahepatic Cholangiocarcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Intrahepatic Cholangiocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Intrahepatic Cholangiocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Intrahepatic Cholangiocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Intrahepatic Cholangiocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Intrahepatic Cholangiocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Intrahepatic Cholangiocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Intrahepatic Cholangiocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Intrahepatic Cholangiocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX Regimen 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Intrahepatic Cholangiocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemigatinibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Intrahepatic Cholangiocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Derazantinibsmall_molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Intrahepatic Cholangiocarcinoma | 3 | Observed | clinicaltrials | graph → |